capstone ai-internship neurology strategy wedge
Layer 5 Wedge Memo
The pre-visit synthesis layer is unowned. That’s the wedge.
This is a 1-page distillation of Competitor Teardowns - Cross-Competitor Analysis + Neurology Subspecialties Map + Week 1-2 - Reddit Patient Pain Points. Read it first, then go to the source docs for evidence.
The problem in one sentence
Every existing neurology AI company helps the doctor during or after the visit (scribe the note, flag a stroke, detect a seizure) — but none of them help the doctor prepare for the visit. The doctor walks into the room without having read the chart, the prior imaging, the between-visit symptoms, or the caregiver’s observations.
The evidence (Layer 5 = 0/3 ownership)
| Layer | What it does | Owned by |
|---|---|---|
| 1 | Audio → text (ASR) | Abridge (Whisper-class) |
| 2 | Text → structured note (LLM) | Abridge (multi-model + Linked Evidence) |
| 3 | Imaging → findings | Viz.ai (50+ 510(k)s, LVO/CTP/ASPECTS) |
| 4 | Signals → events | Ceribell (point-of-care EEG, 95% sens / 97% spec) |
| 5 | Pre-visit synthesis (chart + imaging + wearable + caregiver → briefing) | Nobody |
Cross-competitor 8-pain-point matrix: Abridge covers 2/24, Viz.ai 1/24, Ceribell 1.5/24 — together 4.5/24 (≈19%). The unowned 81% is the wedge.
The 4 pain points no incumbent addresses (verbatim, from Reddit research)
These are the same 4 pain points that all 3 incumbents score zero on. They’re the seed of the product spec.
#2 — 13-year diagnostic journeys. “In my case, 13 years of being treated by several providers like my symptoms were in my imagination until an MRI + clinical history confirmed it was MS.” — u/occasional_nomad, r/MultipleSclerosis (73 pts). The chart is the diagnosis; nobody summarizes it.
#6 — Between-visits data is invisible. Doctors see what happens in the room, not the flares, the heat intolerance, the sleep, the between-seizure events. Wearable + symptom log + diary data exists but isn’t pulled into the visit.
#7 — Caregiver is the real information source. “I type up two notes prior to all appointments. The first one is for the front desk staff… The second is for the doctor.” — dementia caregiver, r/dementia. For dementia, stroke recovery, pediatric, ALS — the caregiver is the primary data source. No scribe includes a HIPAA-compliant caregiver channel. Cleanest gap in the entire AI healthcare landscape.
#1 — Psych attribution as default for “I don’t know.” “It is ok when symptoms are puzzling… to just say, ‘I don’t know’, instead of saying ‘this must be an anxiety disorder.’ The latter statement destroys trust.” — u/Enginerdus, r/MultipleSclerosis (32 pts). The structured symptom timeline that supports an honest “I don’t know” verdict (with a differential) is a product, not a sentence.
Why it’s buildable in 8 weeks
Layer 5 doesn’t need novel research. It needs:
- Chart integration via FHIR (Epic, Cerner) — both have public APIs
- A specialty prompt library — 30+ templates, anchored to the 4 pain points above
- A wearable integration layer — Apple Watch Movement Disorders API, EpiMonitor, StrivePD are all documented
- A caregiver channel — Twilio + a structured intake form + audit log
- A multi-agent LLM — per Sorka et al., 89.2% on neurology boards with off-the-shelf GPT-4 + RAG
The wedge is composition, not research.
Subspecialty shortlist (from the 31-neurology map)
Total opportunity = Prevalence × Pain × Shortage ÷ (AI maturity × Build difficulty). High totals = most leverage.
| Subspecialty | Total | Why |
|---|---|---|
| Headache / Migraine | 25 | 47M US patients, AI greenfield, easiest to build, general-neuro chief complaint |
| Cognitive / Dementia | 25 | 7.4M Alzheimer’s (2026, Alzheimer’s Association Facts & Figures), only ~4 geriatric neuro sites (re-verify against UCNS directory before Week 8) |
| Movement disorders | 15 | UPDRS drift + wearable data; needs StrivePD/Apple integration |
| Epilepsy | 15 | Ceribell/encevis + visit note merge; harder build |
Recommended path for 8 weeks: Headache (transcript-only, fastest to ship) + caregiver-in-the-loop as a cross-cutting feature (works for cognitive/dementia, stroke recovery, severe MS). The caregiver channel differentiates from every scribe in the market.
Why Abridge is the natural Layer 5 tuck-in (strategic view, not a sourced fact)
This is a strategic position derived from the cross-competitor analysis, not a verifiable external claim. Reasoning:
- Abridge has the strongest position to build Layer 5 — Epic integration (300+ systems), specialty templates (55, per Fierce Healthcare June 2025), KLAS-leading — but explicitly does not own longitudinal chart synthesis, the caregiver channel, or between-visit data.
- Their CEO (cardiologist Shiv Rao) frames Abridge as “the most initial wedge into a much larger opportunity” — meaning they know Layer 5 is the next move.
- Therefore (strategic inference): the right play is to build the Layer 5 thin slice, validate it, and become the obvious Layer 5 tuck-in. This is positioning for the Week 8 deck, not an exit plan.
What this memo is NOT
- Not a final subspecialty pick — that’s still a team decision; the memo says Headache + Caregiver is the recommended path, not the only path
- Not an architecture doc — Layer 5 components are listed but not designed; that’s Week 3-4 work
- Not the Week 8 deck — this is the strategic anchor the deck is built on; the deck is the delivery form
- Not a market sizing — TAM/SAM/SOM still needs the pricing data from the 3 teardowns, scoped to the chosen subspecialty
What to do with this memo
- First team meeting: lead with the “0/3 ownership” table + the 4 unowned pain points. Don’t lead with subspecialty — that comes after the wedge is shared.
- Friend’s first doctor interview: anchor every question to the 4 pain points. If the doctor doesn’t see 1-2 of them, the wedge for that subspecialty is weaker than the map suggests.
- Ask Amar/Aditya about GastroNote: send them this memo + the 1-sentence version (“we’re building pre-visit synthesis for neurology — are you already there?”). Their answer shapes whether to compete, partner, or pivot.
- Week 3 training experiment: pick the subspecialty after the doctor interview validates the 4 pain points for that condition, not before. Headache is the safest bet, but don’t anchor to it.
Sources (clickable)
- Competitor Teardowns - Cross-Competitor Analysis — the 0/3 Layer 5 evidence, full matrix
- Competitor Teardown - Abridge — 28KB, 6 customer quotes, JAMA 6-system study
- Competitor Teardown - Viz.ai — 57KB, 11 clinician quotes, NTAP $1,040/use
- Competitor Teardown - Ceribell — 48KB, 95% sens / 97% spec
- Neurology Subspecialties Map — 31 subspecialties, 5-dimension scoring
- Week 1-2 - Reddit Patient Pain Points — 12+ threads, 4 pain points cited above
- Week 1 - Neurology Research — 16-competitor landscape
- Week 1-2 - Research Papers — 34 academic papers tiered
Last updated: 2026-07-07 12:05 EDT